Volume 152, Issue 5, Pages 1090-1099.e1 (April 2017) Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation  David Goldberg, Ivo C. Ditah, Kia Saeian, Mona Lalehzari, Andrew Aronsohn, Emmanuel C. Gorospe, Michael Charlton  Gastroenterology  Volume 152, Issue 5, Pages 1090-1099.e1 (April 2017) DOI: 10.1053/j.gastro.2017.01.003 Copyright © 2017 AGA Institute Terms and Conditions

Figure 1 (A) Diagnosis distribution among patients with an incident diagnosis of compensated cirrhosis in HealthCore, 2006–2014. (B) Diagnosis distribution among patients with an incident diagnosis of CLF in HealthCore, 2006–2014. (C) Diagnosis distribution among patients with an incident diagnosis of HCC in HealthCore, 2006–2014. ∗Data through June 30, 2014. Gastroenterology 2017 152, 1090-1099.e1DOI: (10.1053/j.gastro.2017.01.003) Copyright © 2017 AGA Institute Terms and Conditions

Figure 2 (A) Absolute number of new waitlistings for CLF in the United States by etiology of liver disease, 2002–2015. (B) Absolute number of new waitlistings for HCC in the United States by etiology of liver disease, 2002–2015. (C) Percentage of new waitlistings for CLF in the United States by etiology of liver disease, 2002–2015. (D) Percentage of new waitlistings for HCC in the United States by etiology of liver disease, 2002–2015. ∗Data began on February 27, 2002. Gastroenterology 2017 152, 1090-1099.e1DOI: (10.1053/j.gastro.2017.01.003) Copyright © 2017 AGA Institute Terms and Conditions

Figure 3 (A) Absolute number of LTs for CLF in the United States by etiology of liver disease, 2002–2015. (B) Absolute number of liver transplants for HCC in the United States by etiology of liver disease, 2002–2015. (C) Percentage of liver transplants for CLF in the US by etiology of liver disease, 2002–2015. (D) Percentage of liver transplants for HCC in the US by etiology of liver disease, 2002–2015. ∗Data began on February 27, 2002. Gastroenterology 2017 152, 1090-1099.e1DOI: (10.1053/j.gastro.2017.01.003) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 1 Part D prescription drug event data on Medicare beneficiaries with Medicare Part D prescription coverage. Gastroenterology 2017 152, 1090-1099.e1DOI: (10.1053/j.gastro.2017.01.003) Copyright © 2017 AGA Institute Terms and Conditions